Concepedia

N. Anderson

NA

Statistics

Publications

8

Citations

234

H-Index

8

Active since

1980

Affiliations

Global Cancer Institute(Current)

N. Anderson is an author at Global Cancer Institute specializing in pharmacology, chemotherapy, and medicine.

Publications per year

1980–1998

8

Publications

8

Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo.

Rudolph M. Navari, Stefan Madajewicz, N. Anderson et al. · Journal of Clinical Oncology · 1995 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +15

Controversial issues in 5-fluorouracil infusion use. Dose intensity, treatment duration, and cost comparisons.

N. Anderson, J. Lokich · PubMed · 1992 · 43 citations

Medicine, Oncology, Pharmacology +14

A phase I clinical trial of combined fluoropyrimidines with leucovorin in a 14-day infusion. Demonstration of biochemical modulation

N. Anderson, Jacob J. Lokich, Murray M. Bern et al. · Cancer · 1989 · 36 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Pancreatic alpha cell tumors: Case report and review of the literature

Jacob J. Lokich, N. Anderson, Anna Rossini et al. · Cancer · 1980 · 17 citations · Full text

Medicine, Oncology, Pharmacology +15

Ifosfamide continuous infusion without mesna. A phase I trial of a 14‐day cycle

Jacob J. Lokich, N. Anderson, Murray M. Bern et al. · Cancer · 1991 · 15 citations

Medicine, Hematology, Pharmacology +14

1–5 of 8